Skip to Content
Merck

204919

Yttrium(III) chloride hexahydrate

99.999% trace metals basis

Synonym(s):

Yttrium trichloride hexahydrate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
YCl3 · 6H2O
CAS Number:
10025-94-2
Molecular Weight:
303.36
NACRES:
NA.23
PubChem Substance ID:
24852299
UNSPSC Code:
12352302
EC Number:
233-801-0
MDL number:
MFCD00149941
Assay:
99.999% trace metals basis
Form:
solid

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

IINACGXCEZNYTF-UHFFFAOYSA-K

InChI

1S/3ClH.6H2O.Y/h3*1H;6*1H2;/q;;;;;;;;;+3/p-3

SMILES string

[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].Cl[Y](Cl)Cl

assay

99.999% trace metals basis

form

solid

reaction suitability

core: yttrium

impurities

≤15.0 ppm Trace Rare Earth Analysis

mp

100 °C (dec.) (lit.)

density

2.18 g/mL at 25 °C (lit.)

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

signalword

Danger

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Skin Sens. 1B

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000455064
0000455064
0000434567
0000434567
0000134878

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Acceleration of the substitution of silanes with Grignard reagents by using either LiCl or YCl3/MeLi.
Naoki Hirone et al.
Angewandte Chemie (International ed. in English), 49(42), 7762-7764 (2010-09-08)
S Hirano et al.
Toxicology and applied pharmacology, 121(2), 224-232 (1993-08-01)
Although radioactive yttrium (Y) has been used for medical treatment, little attention has been directed toward the toxicity of Y. We report time-course and dose-related changes in tissue distribution, subcellular localization, clearance, and acute toxicity of iv-injected yttrium chloride (YCl3)
F Zhang et al.
Physical review letters, 101(14), 148101-148101 (2008-10-15)
Negatively charged globular proteins in solution undergo a condensation upon adding trivalent counterions between two critical concentrations C and C, C <C. This reentrant condensation behavior above C is caused by short-ranged electrostatic interactions between multivalent cations and acidic residues
K Marubashi et al.
Toxicology letters, 99(1), 43-51 (1998-11-04)
We investigated pulmonary clearance of yttrium (Y) and acute lung injury following intratracheal instillation (i.t.) of yttrium chloride (YCl3) in saline- or YCl3-pretreated rats (30 days before the second challenge). About 67% of the initial dose of Y remained in
K Schomäcker et al.
Nuklearmedizin. Nuclear medicine, 36(2), 47-51 (1997-03-01)
Possibilities to exercise an influence on the biodistribution of a tumor-affine 153Sm-preparation, samarium-153-nitrilotriacetate (NTA), were tested. Animals experiments on tumor-bearing mice after additional application of EDTMP (ethylenediamine tetramethylene phosphonate) for the reduction of extratumorale liver-radioactivity and yttrium chloride for the
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service